NO144296C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(omega-(benzoylpiperidinyl)-alkyl)-fenothiaziner - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(omega-(benzoylpiperidinyl)-alkyl)-fenothiazinerInfo
- Publication number
- NO144296C NO144296C NO762184A NO762184A NO144296C NO 144296 C NO144296 C NO 144296C NO 762184 A NO762184 A NO 762184A NO 762184 A NO762184 A NO 762184A NO 144296 C NO144296 C NO 144296C
- Authority
- NO
- Norway
- Prior art keywords
- benzoylpiperidinyl
- phenothiazines
- omega
- alkyl
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US59121675A | 1975-06-27 | 1975-06-27 | |
US05/678,575 US4021552A (en) | 1975-06-27 | 1976-04-20 | 10-[ω-(BENZOYLPIPERIDINYL)ALKYL]PHENOTHIAZINES |
Publications (3)
Publication Number | Publication Date |
---|---|
NO762184L NO762184L (sv) | 1976-12-28 |
NO144296B NO144296B (no) | 1981-04-27 |
NO144296C true NO144296C (no) | 1981-08-05 |
Family
ID=27081083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO762184A NO144296C (no) | 1975-06-27 | 1976-06-24 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(omega-(benzoylpiperidinyl)-alkyl)-fenothiaziner |
Country Status (14)
Country | Link |
---|---|
US (1) | US4021552A (sv) |
JP (1) | JPS6036436B2 (sv) |
CA (1) | CA1079277A (sv) |
CH (1) | CH599187A5 (sv) |
DE (1) | DE2628570A1 (sv) |
ES (1) | ES449196A1 (sv) |
FR (1) | FR2316955A1 (sv) |
GB (1) | GB1548284A (sv) |
IL (1) | IL49758A (sv) |
NL (1) | NL7606966A (sv) |
NO (1) | NO144296C (sv) |
PH (1) | PH12436A (sv) |
PT (1) | PT65274B (sv) |
SE (1) | SE409712B (sv) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT335570B (de) * | 1973-11-14 | 1977-03-25 | Danfoss As | Hochbelastbarer ptc-widerstand und verfahren zu seiner herstellung |
US4225641A (en) * | 1977-03-18 | 1980-09-30 | Motohiro Yokomizo | Picture-making device |
JPS57115697U (sv) * | 1981-01-06 | 1982-07-17 | ||
JPH06237B2 (ja) * | 1986-12-26 | 1994-01-05 | 佐内 藤田 | 廃水処理方法及びその装置 |
US4812456A (en) * | 1987-05-13 | 1989-03-14 | Hoechst-Roussel Pharmaceuticals Inc. | 1-(N-(2-alkylthio-10H-phenothiazin-10-yl)alkyl)-4-benzoylpiperidines and pharmaceutical use |
US4822796A (en) * | 1987-06-01 | 1989-04-18 | Helsley Grover C | 1-((Phenothiazin-10-yl)alkyl)-alpha-phenyl-4-piperidinemethanols and pharmaceutical use |
JPH0737355B2 (ja) * | 1989-02-21 | 1995-04-26 | 株式会社新潟鐵工所 | 血液の乾燥処理法 |
JPH0325635U (sv) * | 1989-07-21 | 1991-03-15 | ||
US5225412A (en) * | 1991-04-29 | 1993-07-06 | Hoechst-Roussel Pharmaceuticals Incorporated | Benzoisothiazole-and benzisoxazole-3-carboxamides |
US5143923B1 (en) * | 1991-04-29 | 1993-11-02 | Hoechst-Roussel Pharmaceuticals Incorporated | Benzoisothiazole-and benzisoxazole-3-carboxamides |
US6284279B1 (en) | 1999-12-03 | 2001-09-04 | Avecia, Inc. | Phenothiazine in prill form and method for making the same |
DE10032137B4 (de) * | 2000-07-01 | 2009-04-02 | Allessachemie Gmbh | Verfahren zur Herstellung von Phenothiazin-Granulat mit verbesserten Eigenschaften |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB863243A (en) * | 1958-09-04 | 1961-03-22 | Searle & Co | Improvements in or relating to acylphenothiazines |
US3225037A (en) * | 1959-03-30 | 1965-12-21 | Sterling Drug Inc | 10-[(amino- and acylamino-1-piperidyl) lower-alkyl]-phenothiazines |
GB1177525A (en) * | 1967-04-13 | 1970-01-14 | Leo Ab | New Heterocyclic Aminoketones of Therapeutic Interest |
-
1976
- 1976-04-20 US US05/678,575 patent/US4021552A/en not_active Expired - Lifetime
- 1976-06-10 IL IL49758A patent/IL49758A/xx unknown
- 1976-06-16 SE SE7606847A patent/SE409712B/sv not_active IP Right Cessation
- 1976-06-23 PH PH18598A patent/PH12436A/en unknown
- 1976-06-24 GB GB7626360A patent/GB1548284A/en not_active Expired
- 1976-06-24 NO NO762184A patent/NO144296C/no unknown
- 1976-06-24 PT PT65274A patent/PT65274B/pt unknown
- 1976-06-25 NL NL7606966A patent/NL7606966A/xx not_active Application Discontinuation
- 1976-06-25 CA CA255,762A patent/CA1079277A/en not_active Expired
- 1976-06-25 ES ES449196A patent/ES449196A1/es not_active Expired
- 1976-06-25 FR FR7619434A patent/FR2316955A1/fr active Granted
- 1976-06-25 CH CH819876A patent/CH599187A5/xx not_active IP Right Cessation
- 1976-06-25 DE DE19762628570 patent/DE2628570A1/de active Granted
- 1976-06-26 JP JP51075934A patent/JPS6036436B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
DE2628570C3 (sv) | 1980-10-02 |
SE7606847L (sv) | 1976-12-28 |
JPS525779A (en) | 1977-01-17 |
DE2628570A1 (de) | 1976-12-30 |
FR2316955B1 (sv) | 1980-11-07 |
CH599187A5 (sv) | 1978-05-12 |
FR2316955A1 (fr) | 1977-02-04 |
DE2628570B2 (sv) | 1980-02-07 |
PH12436A (en) | 1979-02-22 |
NO762184L (sv) | 1976-12-28 |
CA1079277A (en) | 1980-06-10 |
ES449196A1 (es) | 1977-07-16 |
US4021552A (en) | 1977-05-03 |
NL7606966A (nl) | 1976-12-29 |
NO144296B (no) | 1981-04-27 |
IL49758A0 (en) | 1976-08-31 |
JPS6036436B2 (ja) | 1985-08-20 |
PT65274A (en) | 1976-07-01 |
GB1548284A (en) | 1979-07-11 |
IL49758A (en) | 1978-12-17 |
SE409712B (sv) | 1979-09-03 |
PT65274B (en) | 1977-12-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO142034C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoletere. | |
NO143219C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser. | |
NO150800C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tricykliske forbindelser | |
NO148712C (no) | Fremgangsmaate ved fremstilling av etylidendiacetat | |
NO155055C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-carboxylsyrederivater. | |
NO150760C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aminotiazoler. | |
NO150360C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacyldipeptider | |
NO151040C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner | |
NO147109C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive diazepin-derivater | |
NO146095C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater | |
NO146865C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 16-dehydro-androstanderivater | |
NO144296C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-(omega-(benzoylpiperidinyl)-alkyl)-fenothiaziner | |
NO146359C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater | |
NO144926C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-benzazolylalkyl-4-substituerte piperidiner | |
NO152007C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 7beta-(syn-2-oksyimino-arylacetamido)-3-(sulfoalkyltetrazol-5-yl-tiometyl)-cephem-4-karboksylsyrer | |
NO151288C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolokinolizindiner | |
NO151319C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive beta-mono-fluormetyl-beta-alanin- og beta-difluormetyl-beta-alanin-forbindelser | |
NO781879L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridobenzodiazepiner | |
NO146060C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-substituerte-5-alkylresorcinol | |
NO151410C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(2-klorethyl)-n-nitrosourea-forbindelser | |
NO140824C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 7alfa-hydroxy-oestratriener | |
NO144108C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider | |
NO152128C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-amino-3-benzoylfenylacetamider | |
NO145620C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive depotsteroidestere. | |
NO147485C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater |